2021 / 04

Next Paper
DOI: 10.24075/brsmu.2021.036

ORIGINAL RESEARCH

Features of the pathogenetic mechanisms of tuberculous peritonitis in an experiment

Plotkin DV1,2, Vinogradova TI3, Reshetnikov MN1, Ariel BM, Zyuzya YuR1, Zhuravlev VYu, Sinitsyn MV1, Bogorodskaya EM1, Yablonsky PK
About authors

1 Moscow Research and Clinical Center for TB Control, Moscow, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

3 Saint-Petersburg State Research Institute of Phtisiopulmonology, St. Petersburg, Russia

Correspondence should be addressed: Dmitry Vladimirovich Plotkin
Ostrovityanova, 1, Moscow, 117997; ur.tsil@31nk

About paper

Author contributions: Plotkin DV, Vinogradova TI, Sinitsyn MV, Bogorodskaya EM — study concept and design development; Plotkin DV, Reshetnikov MN, Zhuravlev VYu, Zyuzya YuR — material collection; Reshetnikov MN, Zhuravlev VYu — statistical processing; Plotkin DV, Vinogradova TI, Ariel BM, Yablonsky PK — analysis of the data obtained; Plotkin DV, Ariel BM, Sinitsyn MV, Bogorodskaya EM — text preparation; Vinogradova TI, Zyuzya YuR, Yablonsky PK — editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Saint Petersburg Research Institute of Phthisiopulmonology (protocol № 73 of December 23, 2020). All manipulations with animals conformed to the requirements of the European Convention for the Protection of Vertebral Animals Used for Experimental and Other Scientific Purposes (CETS # 170) and followed guidelines provided in GOST 33216-2014 Rules for Working with Laboratory Rodents and Rabbits.

Received: 2021-06-30 Accepted: 2021-07-21 Published online: 2021-08-04
|
  1. Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019; 367: l5770. PubMed PMID: 31649096. DOI: 10.1136/bmj.l5770.
  2. WHO. Global Tuberculosis Report 2020. World Health Organization, Geneva, 2020. Available at: https://www.who.int/ tb/publications/global_report/en.
  3. Mirzojan JeZ. Tuberkulez kishechnika i brjushiny. V knige: V. L. Jejnis, redaktor. Mnogotomnoe rukovodstvo po tuberkulezu. T. 3. M.: Medgiz, 1960; s. 125–146. Russian.
  4. Onosovskij VV. O lechenii tuberkuleznogo peritonita u detej, po materialam Ol'ginskoj detskoj bol'nicy v Moskve za 36 let. Problemy tuberkuleza. 1923; 5–6 (1): 148–155. Russian.
  5. Savonenkova LN, Arjamkina OL. Patogenez i morfogenez abdominal'nogo tuberkuleza s porazheniem gastrointestinal'nogo trakta. Nizhegorodskij medicinskij zhurnal. 2006; 2: 89–94. Russian.
  6. Dülger AC, Karadaş S, Mete R, Türkdoğan MK, Demirkıran D, Gültepe B. Analysis of cases with tuberculous peritonitis: a singlecenter experience. Turk J Gastroenterol. 2014; 25 (1): 72–8. PubMed PMID: 24918135. DOI: 10.5152/tjg.2014.5145.
  7. Bellendir JeN. Patogenez vnelegochnyh lokalizacij tuberkuleza. V knige: A. V. Vasil'ev, redaktor. Vnelegochnyj tuberkulez. SPb., 2000; s. 36–48. Russian.
  8. Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med. 1969; 281 (20): 1091–4. PubMed PMID: 5824174. DOI: 10.1056/ NEJM196911132812003.
  9. Bezredka AM. Ocherki po immunitetu. M–L., 1929; 267 c. Russian.
  10. Kishenskij DN. Vlijanie chrevosechenija na tuberkulez brjushiny. Jeksperimental'noe issledovanie [dissertacija]. M.: Tovarishhestvo tipografii A. I. Mamontova, 1894; 82 c. Russian.
  11. Lurie MB. The fate of tubercle bacilli in the organs of reinfected rabbits. J Exp Med. 1929; 50 (6): 747–765. PubMed PMID: 19869661. DOI: 10.1084/jem.50.6.747.
  12. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002; 168 (9): 4620–7. PubMed PMID: 11971010. DOI: 10.4049/jimmunol.168.9.4620.
  13. Brissot E, Bernard DG, Loréal O, Brissot P, Troadec MB. Too much iron: A masked foe for leukemias. Blood Rev. 2020; 39: 100617. PubMed PMID: 31753415. DOI: 10.1016/j.blre.2019.100617.
  14. Shekunova EV, Kovaleva MA, Makarova MN, Makarov VG. Vybor dozy preparata dlja doklinicheskogo issledovanija: mezhvidovoj perenos doz. Vedomosti Nauchnogo centra jekspertizy sredstv medicinskogo primenenija. 2020; 10 (1): 19–28. DOI: 10.30895/1991-2919-2020-10-1-19-28. Russian.
  15. Zemskova ZS, Arijel BM, Babaeva IJu, Erohin VV, Zjuzja JuR., Lepeha LN. Tuberkulez (vklad otechestvennyh uchenyh HH stoletija v razvitie ftiziatrii). M.: Izd-vo Sechenovskogo universiteta, 2020; 352 s. Russian.
  16. Shepelkova GS, Evstifeev VV, Apt AS. Issledovanie molekuljarnyh mehanizmov patogeneza tuberkuleza na jeksperimental'nyh modeljah. Tuberkulez i bolezni legkih. 2012; 89 (7): 3–11. Russian.
  17. Singhal A, Aliouat el M, Hervé M, Mathys V, Kiass M, Creusy C. et al. Experimental tuberculosis in the Wistar rat: a model for protective immunity and control of infection. PLoS One. 2011; 6 (4): e18632. PubMed PMID: 21533270. DOI: 10.1371/journal. pone.0018632.
  18. Graur D, Duret L, Gouy M. Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature. 1996; 379 (6563): 333–5. PubMed PMID: 8552186. DOI: 10.1038/379333a0.
  19. Bujanov VM, Rodoman GV, Belous GG. Jeksperimental'naja model' ostrogo gnojnogo peritonita. Hirurgija. Zhurnal im. N. I. Pirogova. 1997; 1: 25–28. Russian.
  20. Knutsen KM, Skuterud B, Halvorsen S. Hemoperfusjon ved forgiftninger [Hemoperfusion in poisoning]. Tidsskr Nor Laegeforen. 1979; 99 (3): 172–4. PubMed PMID: 419497.
  21. Dobbie JW. Serositis: comparative analysis of histological findings and pathogenetic mechanisms in nonbacterial serosal inflammation. Perit Dial Int. 1993; 13 (4): 256–69. PubMed PMID: 8241326.
  22. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun. 2001; 69 (3): 1847–55. PubMed PMID: 11179363. DOI: 10.1128/IAI.69.3.1847-1855.2001.
  23. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002; 168 (9): 4620–7. PubMed PMID: 11971010. DOI: 10.4049/jimmunol.168.9.4620.
  24. Saleh MA, Ramadan MM, Arram EO. Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and susceptibility to pulmonary and peritoneal tuberculosis. APMIS. 2017; 125 (6): 558–64. PubMed PMID: 28332241. DOI: 10.1111/apm.12680.
  25. Aleshkin VA, Lozhkina AN, Zagorodnjaja JeD. Immunologija reprodukcii. Chita, 2004; 79 s. Russian.
  26. Krekova JuV. Izmenenie funkcional'nogo sostojanija immunnoj sistemy u bol'nyh razlichnymi tipami saharnogo diabeta [dissertacija]. 2002; 122 s. Russian.
  27. Shatalin JuV, Naumov AA, Pocelueva MM. Izmenenie sostava kletochnyh populjacij i urovnja aktivnyh form kisloroda v krovi i asciticheskoj zhidkosti opuholenositelja. Citologija. 2010; 52 (2): 131–35. Russian.
  28. Rohit A, Abraham G. Peritoneal dialysis related peritonitis due to Mycobacterium spp.: A case report and review of literature. J Epidemiol Glob Health. 2016; 6 (4): 243–8. PubMed PMID: 27443487. DOI: 10.1016/j.jegh.2016.06.005.
  29. Pornprasert S, Leechanachai P, Klinbuayaem V, Leenasirimakul P, Promping C, Inta P, et al. Unmasking tuberculosis-associated immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy. Asian Pac J Allergy Immunol. 2010; 28 (2–3): 206–9. PubMed PMID: 21038792.
  30. Roth S, Delmont E, Heudier P, Kaphan R, Cua E, Castela J, et al. Anticorps anti-TNF alpha (infliximab) et tuberculose: à propos de trois cas [Anti-TNF alpha monoclonal antibodies (infliximab) and tuberculosis: apropos of 3 cases]. Rev Med Interne. 2002; 23 (3): 312–6. PubMed PMID: 11928379. DOI: 10.1016/s02488663(01)00556-2.
  31. Moule MG, Cirillo JD. Mycobacterium tuberculosis Dissemination Plays a Critical Role in Pathogenesis. Front Cell Infect Microbiol. 2020; 10: 65. PubMed PMID: 32161724. DOI: 10.3389/ fcimb.2020.00065.